Have a personal or library account? Click to login
State Regulation of Biomedical Citizen Science Cover

State Regulation of Biomedical Citizen Science

Open Access
|Dec 2022

References

  1. 1Bateman-House, A and Robertson, CT. 2018. The Federal Right to Try Act of 2017-A Wrong Turn for Access to Investigational Drugs and the Path Forward. JAMA Internal Medicine, 178(3): 321322. DOI: 10.1001/jamainternmed.2017.8167
  2. 2Brown, KV. 2019. Biohacker Investigation is Dropped by California Medical Board. Bloomberg. Available at https://www.bloomberg.com/news/articles/2019-10-15/biohacker-investigation-is-dropped-by-california-medical-board [Last accessed June 1, 2022].
  3. 3Caplan, AL and Bateman-House, A. 2020. The danger of DIY vaccines. Science, 369(6507): 1035. DOI: 10.1126/science.abe4440
  4. 4Cohen, DS, Donley, G and Rebouche, R. 2023. The New Abortion Battleground. Columbia Law Review. In Press. DOI: 10.2139/ssrn.4032931
  5. 5Estep, PW and Church, GM. 2020. Transparency is key to ethical vaccine research. Science, 370(6523): 14221423. DOI: 10.1126/science.abf4851
  6. 6Evans, BJ. 2020. Minding the Gaps in Regulation of Do-It-Yourself Biotechnology. DePaul Journal of Health Care Law, 21(1). DOI: 10.2139/ssrn.3628733
  7. 7Evans, BJ. 2021. Programming Our Genomes, Programming Ourselves. In: Cohen, IG, Farahany, NA, Greely, HT and Shachar, C (eds.), Consumer Genetic Technologies: Ethical and Legal Considerations, 129145. Cambridge University Press. DOI: 10.1017/9781108874106.014
  8. 8Fernandez Lynch, H, Sarpatwari, A, Vonderheide, RH and Zettler, PJ. 2020. Right to Try Requests and Oncologists’ Gatekeeping Obligations. Journal of Clinical Oncology, 38(2): 111114. DOI: 10.1200/JCO.19.01741
  9. 9Four Thieves Vinegar Collective. 2022. Abortion Care. Available at https://fourthievesvinegar.org/abortion-care/ [Last accessed 1 September 2022].
  10. 10Guerrini, CJ, Pearlman, A and Zettler, PJ. 2021. The Biden-Harris FDA should make friends with independent researchers. STAT. Available at https://www.statnews.com/2021/01/26/the-biden-harris-fda-should-make-friends-with-independent-researchers/ [Last accessed 1 September 2022].
  11. 11Guerrini, CJ, Sherkow, JS, Meyer, MN and Zettler, PJ. 2020. Self-experimentation, ethics, and regulation of vaccines. Science, 369(6511): 15701572. DOI: 10.1126/science.abe1963
  12. 12Guerrini, CJ, Sherkow, JS and Zettler, PJ. 2021. Finding a regulatory balance for genetic biohacking. In: Cohen, IG, Farahany, NA, Greely, HT and Shachar, C (eds.), Consumer Genetic Technologies: Ethical and Legal Considerations, 157169. Cambridge University Press. DOI: 10.1017/9781108874106.016
  13. 13Guerrini, CJ, Wexler, A, Zettler, PJ and McGuire, AL. 2019. Biomedical Citizen Science or Something Else? Reflections on Terms and Definitions. American Journal of Bioethics, 19(8): 1719. DOI: 10.1080/15265161.2019.1619880
  14. 14Hutt, PB, Merril, RA, Grossman, LA, Cortez, N, Lietzan, E and Zettler, PJ. 2022. Food and Drug Law: Cases and Materials. Foundation Press.
  15. 15Keller, J. 2017. Wyoming Has Effectively Made Citizen Science a Crime. Pacific Standard. Pacific Standard. [online access at https://psmag.com/news/in-wyoming-citizen-science-can-get-you-jail-time last accessed 1 September 2022].
  16. 16Lewis, MS. 2020. Innovating Federalism in the Life Sciences. Temple Law Review, 92: 383.
  17. 17Marks, M. 2020. Controlled Substance Regulation for the Covid-19 Mental Health Crisis. Administrative Law Review, 72(649).
  18. 18Marlan, D. 2019. Beyond Cannabis: Psychedelic Decriminalization and Social Justice. Lewis & Clark Law Review, 23(951).
  19. 19McIntosh, T, Pendo, E, Walsh, H, Baldwin, K and DuBois, JM. 2021. Protecting Patients from Egregious Wrongdoing by Physicians: Consensus Recommendations from State Medical Board Members and Staff. Journal of Medical Regulation, 107(5). DOI: 10.30770/2572-1852-107.3.5
  20. 20Mehlman, MJ and Conlon, RA. 2021. Governing Nontraditional Gene Editing. In: Cohen, IG, Farahany, NA, Greely, HT and Shachar, C (eds.), Consumer Genetic Technologies: Ethical and Legal Considerations, 145157. Cambridge University Press. DOI: 10.1017/9781108874106.015
  21. 21Noah, L. 2016. State Affronts to Federal Primacy in the Licensure of Pharmaceutical Products. Michigan State Law Review, 2016(1).
  22. 22RadVac. Available at https://radvac.org/ [Last accessed June 1, 2022].
  23. 23Rasmussen, LM, Guerrini, CJ, Kuiken, T, Nebeker, C, Pearlman, A, Ware, SB, Wexler, A and Zettler, PJ. 2020. Realizing Present and Future Promise of DIY Biology and Medicine through a Trust Architecture. Hastings Center Report, 50(6): 1014. DOI: 10.1002/hast.1194
  24. 24Regalado, A. 2022. Where to Get Abortion Pills and How to Use Them. MIT Technology Review. [online access at https://www.technologyreview.com/2022/06/15/1054013/where-get-abortion-pills-how-to-use-them/ last accessed 1 September 2022].
  25. 25Richardson, L. 2019. Lawsuit Highlights State Role in Regulating Regenerative Medicine. Pew Trusts. Available at https://www.pewtrusts.org/en/research-and-analysis/articles/2019/05/13/lawsuit-highlights-state-role-in-regulating-regenerative-medicine [Last accessed June 1, 2022].
  26. 26Shah, SK and Jamrozik, E. 2020. Do-It-Yourself Vaccines for COVID-19. Scientific American.
  27. 27Sharkey, CM. 2015. States vs. FDA. George Washington Law Review, 83(1609).
  28. 28Smith, WR and Appelbaum, PS. 2021. Two Models of Legalization of Psychedelic Substances: Reasons for Concern. JAMA, 326(8): 697698. DOI: 10.1001/jama.2021.12481
  29. 29Trejo, M, Canfield, I, Brooks, WB, Pearlman, A and Guerrini, C. 2021. “A Cohort of Pirate Ships”: Biomedical Citizen Scientists’ Attitudes Toward Ethical Oversight. Citizen Science: Theory and Practice, 6(1): 15. DOI: 10.5334/cstp.360
  30. 30Wexler, A. 2015. A pragmatic analysis of the regulation of consumer transcranial direct current stimulation (TDCS) devices in the United States. Journal of Law and the Biosciences, 2(3): 669-696. DOI: 10.1093/jlb/lsv039
  31. 31Wiley, LF, McCuskey, EY, Lawrence, MB and Fuse Brown, EC. 2021. Health Reform Reconstruction. UC Davis Law Review, 55(657).
  32. 32Zettler, PJ. 2016. What lies ahead for FDA regulation of tDCS products? Journal of Law and the Biosciences. 3(2): 318323. DOI: 10.1093/jlb/lsw024
  33. 33Zettler, PJ. 2017. Pharmaceutical Federalism. Indiana Law Journal, 92: 845900.
  34. 34Zettler, PJ. 2021. The FDA’s Power over Non-Therapeutic Uses of Drugs and Devices. Washington & Lee Law Review, 78(379).
  35. 35Zettler, PJ, Guerrini, CJ and Sherkow, JS. 2019. Regulating genetic biohacking. Science, 365(6448): 3436. DOI: 10.1126/science.aax3248
  36. 36Zettler, PJ and Sarpatwari, A. 2022. State Restrictions on Mifepristone Access – The Case for Federal Preemption. New England Journal of Medicine, 386(8): 705707. DOI: 10.1056/NEJMp2118696
DOI: https://doi.org/10.5334/cstp.526 | Journal eISSN: 2057-4991
Language: English
Submitted on: Jun 1, 2022
Accepted on: Sep 16, 2022
Published on: Dec 15, 2022
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2022 Patricia J. Zettler, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.